Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NUVB is expected to report earnings to fall 1,477.00% to -13 cents per share on August 06
Q2'26
Est.
$-0.14
Q1'26
Est.
$0.01
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
Q2'25
Est.
$-0.17
The last earnings report on May 04 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 853.98K shares outstanding, the current market capitalization sits at 2.01B.